Ganirelix (or Ganirelixum) is a synthetic peptide molecule made up of covalently bonded 10 amino acids. The structural order of peptides determines their biological properties. The minor change in the structure of therapeutic peptides can have a significant impact on their biological behaviors. In this regard, the ganirelix drug product was sterilized at 121°C for 15 mins and further exposed to thermal and humidity at 25°C/60%RH and 40°C/75% RH for 6 months. The ganirelix was isolated using flash chromatography and freeze- dried. We applied Fourier transform infrared (FTIR) and Ultraviolet -Visible (UV-Vis) spectroscopic techniques to investigate temperature and humidity effects on the chemical structure of Ganirelix. FTIR scans were conducted in the wave number range of 4000 – 400cm-1 and UV scans were conducted in the wavelength range of 190 – 400nm. The attained IR stretching vibrations, maximum UV absorbance results, overlayed IR and UV-Vis spectra of Ganirelix in temperature stressed generic drug product is closely comparable to reference listed drug (RLD). In addition, it showed homology in the finger print region of the FTIR with those of the reference listed drug (RLD).
Cite this article:
Kumarswamy Ummiti , J.V. Shanmukha Kumar. Applications of Fourier Transform Infrared and UV-Visible Spectroscopy for the demonstrating sameness of Ganirelix peptide in Liquid Injection Formulation. Research Journal of Pharmacy and Technology. 2022; 15(4):1709-2. doi: 10.52711/0974-360X.2022.00286
Kumarswamy Ummiti , J.V. Shanmukha Kumar. Applications of Fourier Transform Infrared and UV-Visible Spectroscopy for the demonstrating sameness of Ganirelix peptide in Liquid Injection Formulation. Research Journal of Pharmacy and Technology. 2022; 15(4):1709-2. doi: 10.52711/0974-360X.2022.00286 Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-4-52
1. Enis O, Gabriel SR and Kutluk O. Luteal phase GnRHa trigger in random start fertility preservation cycles. Journal of Assisted Reproduction and Genetics. 2012; 29(6): 503-505.
2. Miriam H, Jose MT, Maria S, et al. Drug tolerability in assisted reproduction techniques: a longitudinal study. Systems Biology in Reproductive Medicine. 2012; 58(5): 245-254.
3. Pandey R, Singh AV, Pandey A, et al. Protein and Peptide Drugs: A Brief Review. Research Journal of Pharmacy and Technology. 2009; 2(2): 228-233.
4. U.S. Food and drug administration (1999) Antagon (Ganirelix Acetate). Available from URL: http://accessdata.fda.gov/drugsatfda_docs/ nda/99/ 21057_Antagon.cfm.
5. European Commission (2000) Orgalutran. Available from URL: http://drugs.com/uk/orgalutran.html.
6. Larisa Wu, Chen F, Lee SL, et al. Building Parity between Brand and Generic Peptides: Regulatory and Scientific Considerations for Quality of Synthetic Peptides. International Journal of Pharmaceutics. 2017; 518(1-2):320 -334.
7. Rajesh B, Syeda RN, Nivethithai P, et al. Approaches and Challenges of Protein and Peptide Drug Delivery Systems. Research Journal of Pharmacy and Technology. 2010; 3(2): 379-384.
8. Pradeep K, Priyadarshini RL, Vijay K. Peptide Microarray Production on a Solid Support and its Applications. Research Journal of Pharmacy and Technology. 2012; 5(8):1015-1024.
9. Larisa, Wu. In Peptide Therapeutics: Strategy and Tactics for Chemistry, Manufacturing, and Controls. Regulatory Considerations for Peptide Therapeutics, edited by Srivastava V. Royal Society of Chemistry, London. 2019; 1st ed: pp. 1-30.
10. Srinivas L, Manikanta V and Jaswitha M. Protein and Peptide Drug Delivery - A Brief Review. Research Journal of Pharmacy and Technology. 2019; 12(3): 1369-1382.
11. Bakshi K, Liyanage MR, Volkin DB, et al. Fourier Transform Infrared Spectroscopy of Peptides. In: Nixon A. (eds) Therapeutic Peptides. Methods in Molecular Biology (Methods and Protocols). Humana Press, Totowa.2014.
12. Santhanabharathi N, Anupama N, Vivek P, et al. In Silico Anti-HIV Analysis of FTIR Identified Bioactive Compounds Present in Vitex altissima L and Vitex leucoxylon L. Research Journal of Pharmacy and Technology. 2019; 12(4):1773-1782.
13. Venyaminov SY and Kanin NN. Quantitative IR spectrophotometery of peptide compounds in water (H2O) solutions. Spectral parameters of amino acid residue absorption bands. Biopolymers. 1990; 30(13-14):1243–1257.
14. Saraswathi K, Sivaraj C, Jenifer A, et al. Antioxidant, Antibacterial activities, GCMS and FTIR Analysis of Ethanol bark extract of Capparis sepiaria L. Research Journal of Pharmacy and Technology. 2020; 13(5): 2144-2150.
15. Hemashree T, Prasunna Sree G and Sakthiselvan P. Synthesis of Keratin Nanoparticle and Characterization using FTIR. Research Journal of Pharmacy and Technology. 2019; 12(6): 2664-2668.
16. Van de Weert M, Haris PI, Hennink WE, et al. Fourier transform infrared spectrometric analysis of protein conformation: effect of sampling method and stress factors. Anal Biochem. 2001; 297(2): 160–169.
17. Meghana JR, Anitha R, Rajeshkumar S, et al. Characterisation of Cumin oil mediated silver nanoparticles using UV-visible spectrophotometer and TEM. Research Journal of Pharmacy and Technology. 2019; 12(10):4931-4933.
18. Pignataro MF, Herrera MG and Dodero VI. Evaluation of Peptide/Protein Self-Assembly and Aggregation by Spectroscopic Methods. Molecules. 2020; 25(20):4854.
19. Vijay BN, Venkatesh DR and Chakravarthy IE. UV-Visible Spectrophotometric Analysis of Zolpidem Tartrate in Pharmaceutical Formulation. Research Journal of Pharmacy and Technology. 2011; 4(6): 917-919.
20. Sasikala M, Mohan S, Gokilambal V, et al. Validated UV-Visible Spectroscopic Analytical method development and stability studies on Oseltamivir. Research Journal of Pharmacy and Technology. 2020; 13(9):4323-4328.
21. Eigil BN and John AS. The absorption spectra of simple amides and peptides. The Journal of Physical Chemistry. 1967; 71(7): 2297-2304.